Rare occurrence of JAK3 mutations in natural killer cell neoplasms in Japan

Leukemia and Lymphoma

Volumn 55, Issue 4, 2014, Pages 962-963

  Kimura, Hiroshi ^a   Karube, Kennosuke ^b   Ito, Yoshinori ^a   Hirano, Kyoko ^b   Suzuki, Michio ^a   Iwata, Seiko ^a   Seto, Masao ^a,b  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRESSIVE NK CELL LEUKEMIA; COMPARATIVE GENOMIC HYBRIDIZATION; GENE; GENE DELETION; GENE EXPRESSION PROFILING; GENE FREQUENCY; GENE MUTATION; HUMAN; JAK3 GENE; JAPAN; LETTER; NK T CELL LYMPHOMA; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SEQUENCE ANALYSIS; GENETICS; MUTATION;

JANUS KINASE 3;

HUMANS; JANUS KINASE 3; JAPAN; LYMPHOMA, EXTRANODAL NK-T-CELL; MUTATION;

EID: 84903815486     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2013.819577     Document Type: Letter

References (12)

1. Kwong YL, Anderson BO, Advani R, et al. Management of T-cell and natural-killer-cell neoplasms in Asia: consensus statement from the Asian Oncology Summit 2009. Lancet Oncol 2009;10:1093-1101.
2. Tse E, Kwong YL. Practical management of natural killer/T-cell lymphoma. Curr Opin Oncol 2012;24:480-486.
3. Koo GC, Tan SY, Tang T, et al. Janus kinase 3-activating mutations identified in natural killer/T-cell lymphoma. Cancer Discov2012;2:591-597.
4. Karube K, Nakagawa M, Tsuzuki S, et al. Identification ofFOXO3 and PRDM1 as tumor-suppressor gene candidates in NK-cell neoplasms by genomic and functional analyses. Blood 2011;118:3195-3204.
5. Huang Y, de Reynies A, de Leval L, et al. Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type. Blood 2010;115:1226-1237.
6. Iqbal J, Kucuk C, Deleeuw RJ, et al. Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies. Leukemia 2009; 23: 1139-1151.
7. NakashimaY, TagawaH, SuzukiR, et al. Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal NK/T-cell lymphoma, nasal type. Genes Chromosomes Cancer 2005; 44: 247-255.
8. Malinge S, Ragu C, Della-Valle V et al. Activating mutations in human acute megakaryoblastic leukemia. Blood 2008; 112: 4220-4226.
9. Bains T, Heinrich MC, Loriaux MM, et al. Newly described activating JAK3 mutations in T-cell acute lymphoblastic leukemia. Leukemia 2012; 26: 2144-2146.
10. Quintanilla-Martinez L, Kimura H, Jaffe ES. EBV+ T-cell lymphoma of childhood. In: Swerdlow SH, Campo E, Harris NL, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2008. pp 278-280.
11. Kimura H, Ito Y, Kawabe S, et al. EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases. Blood 2012;119:673-686.
12. Iwata S, Yano S, Ito Y, et al. Bortezomib induces apoptosis in T lymphoma cells and natural killer lymphoma cells independent of Epstein-Barr virus infection. Int J Cancer 2011;129:2263-2273.